University Medical Center Utrecht Partners with Paige to Conduct Health Economics Study and to Evaluate AI in Clinical Setting

Paige Prostate Suite and Breast Lymph Node solutions will be deployed and evaluated at UMC Utrecht UMC Utrecht, one of the largest hospitals in the Netherlands, was one of the first in the world to implement full-scale digital pathology solutions in its laboratories NEW YORK–(BUSINESS WIRE)–Paige, a global leader in end-to-end digital pathology solutions and … [Read more…]

Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires

SAN DIEGO–(BUSINESS WIRE)–Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the addition of three key new members to its leadership team. Aaron Mishel has joined the company as Chief Financial Officer, David Houck as Vice President of CMC (Chemistry, Manufacturing … [Read more…]

AscellaHealth Ranked Number 238 Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™

BERWYN, Pa.–(BUSINESS WIRE)–AscellaHealth today announced it ranked 238 on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 28th year. AscellaHealth grew 640% during this three-year period from 2018 to 2021. AscellaHealth’s president and chief executive officer, … [Read more…]

Global Alpha Glucosidase Inhibitors Market Research Report 2022 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Alpha Glucosidase Inhibitors Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The alpha glucosidase inhibitors market is poised to grow by $567.96 mn during 2022-2026, accelerating at a CAGR of 2.51% The market is driven by increase in awareness of diabetes and growing initiatives, growing awareness about benefits of alpha glucosidase … [Read more…]

Trialbee Announces Trialbee Honey™ Omnichannel, Real-Time Patient Recruitment Tracking for Multiple Recruitment Sources at CNS Summit 2022

CHAPEL HILL, N.C. & MALMO, Sweden–(BUSINESS WIRE)–Trialbee, the leader in data and technology-based patient recruitment and enrollment for clinical trials, will introduce Trialbee Honey™ Omnichannel, a powerful multichannel approach to global patient recruitment, at CNS Summit on Nov. 17-20 in Boca Raton, Florida. Honey Omnichannel enables tracking for multiple recruitment sources, offering sponsors and CROs … [Read more…]

Genome Insight and Kun-hee Lee Child Cancer & Rare Disease Project Team of SNUH (Seoul National University Hospital) Made an Agreement About a Pediatric Cancer Whole Genome Collaborative Study

SAN DIEGO–(BUSINESS WIRE)–Genome Insight, a precision medicine whole genome platform company, and Kun-hee Lee Child Cancer & Rare Disease Project Team of SNUH (Seoul National University Hospital), funded by the family of ex-Samsung Group Chairman Kun-hee Lee, announces today a collaborative study for a whole genome sequencing (WGS)-based approach to pediatric solid cancer diagnosis in … [Read more…]

CenterWell Senior Primary Care 2023 Expansion Plan Includes New Markets of Indiana, Mississippi and Virginia

New centers also coming to Kentucky, Louisiana, Nevada, North Carolina, South Carolina, Tennessee and Texas LOUISVILLE, Ky.–(BUSINESS WIRE)–Fast-growing CenterWell Senior Primary Care will continue expanding in 2023, announcing plans to open in new markets including Indiana, Mississippi and Virginia, as well as opening new centers in seven other states where CenterWell already is active. CenterWell … [Read more…]

Insights on the Intracranial Aneurysm Global Market to 2027 – US Market is Estimated at $294.1 Million – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Intracranial Aneurysm: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Intracranial Aneurysm estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027. Endovascular Coiling, one … [Read more…]

Short Bowel Syndrome Drug Pipeline Research Report 2022 – Comprehensive Insights About 18+ Companies and 20+ Pipeline Drugs – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Short Bowel Syndrome – Pipeline Insight, 2022” report has been added to ResearchAndMarkets.com’s offering. This “Short Bowel Syndrome – Pipeline Insight, 2022” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Short Bowel Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also … [Read more…]

Enveric Biosciences to Participate in A.G.P.’s Virtual Biotech Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences (NASDAQ: ENVB) (”Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, today announced that Avani Kanubaddi, President & COO of Enveric Biosciences, will participate in A.G.P.’s Virtual Biotech Conference to be held from November 30, 2022 … [Read more…]